These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Involvement of leukotrienes in allergic inflammation in mice. Zuany-Amorim C; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1994 May; 257(3):211-6. PubMed ID: 7916299 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of slow-reacting substance-like activity in human anterior uvea. Kulkarni PS; Srinivasan BD Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1201-4. PubMed ID: 3110093 [TBL] [Abstract][Full Text] [Related]
7. A formyl peptide contracts guinea pig lung: role of arachidonic acid metabolites. Shore SA; Stimler-Gerard NP; Smith E; Drazen JM J Appl Physiol (1985); 1987 Dec; 63(6):2450-9. PubMed ID: 2893781 [TBL] [Abstract][Full Text] [Related]
8. Leukotriene synthesis inhibition and receptor blockade do not inhibit hypoxic pulmonary vasoconstriction in sheep. Pearl RG; Prielipp RC Anesth Analg; 1991 Feb; 72(2):169-76. PubMed ID: 1670754 [TBL] [Abstract][Full Text] [Related]
9. Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Hagmann W; Denzlinger C; Keppler D Circ Shock; 1984; 14(4):223-35. PubMed ID: 6096038 [TBL] [Abstract][Full Text] [Related]
10. Leukotrienes and lung disease. O'Driscoll BR; Kay AB Thorax; 1982 Apr; 37(4):241-5. PubMed ID: 6126014 [No Abstract] [Full Text] [Related]
11. Synthesis of slow reacting substance-like activity in rabbit conjunctiva and anterior uvea. Kulkarni PS; Srinivason BD Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1079-85. PubMed ID: 6135672 [TBL] [Abstract][Full Text] [Related]
12. Role of arachidonic acid metabolites in the pathogenesis of acute lung injury. Lonigro AJ; Stephenson AH; Sprague RS Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():421-8. PubMed ID: 1825575 [No Abstract] [Full Text] [Related]
13. [Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis]. Lototskaia LS; Naĭdenova IIu; Il'iasheva LM; Poda GI; Kornilov AI Farmakol Toksikol; 1989; 52(2):59-62. PubMed ID: 2501105 [TBL] [Abstract][Full Text] [Related]
14. Leukotrienes antagonist-inhibitor and the bronchial response to inhaled antigen in actively sensitized guinea-pigs. Marcelle R Arch Physiol Biochem; 1998 Aug; 105(4):358-64. PubMed ID: 9711356 [TBL] [Abstract][Full Text] [Related]
15. Slow-reacting substances and asthma: leukotrienes may hold the key to asthma therapy. Seale JP Med J Aust; 1981 Nov; 2(11):574-5. PubMed ID: 6121283 [No Abstract] [Full Text] [Related]
16. A brief review of preclinical and clinical studies with LY171883 and some comments on newer cysteinyl leukotriene receptor antagonists. Fleisch JH; Cloud ML; Marshall WS Ann N Y Acad Sci; 1988; 524():356-68. PubMed ID: 2837970 [No Abstract] [Full Text] [Related]
17. Structural determination of leukotrienes and lipoxins. Samuelsson B; Hammarström S; Hamberg M; Serhan CN Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():45-71. PubMed ID: 2992247 [No Abstract] [Full Text] [Related]
18. Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat. Cooper DR; Kelliher GJ; Kowey PR Am Heart J; 1988 Nov; 116(5 Pt 1):1194-200. PubMed ID: 3142241 [TBL] [Abstract][Full Text] [Related]
19. Direct chemical ionization mass spectrometry of underivatized arachidonic acid metabolites: application to leukotriene biosynthesis. Gut J; Jamieson GC; Trudell JR Basic Life Sci; 1988; 49():185-9. PubMed ID: 2854981 [No Abstract] [Full Text] [Related]